The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
The Pathogenesis, Epidemiology and Management of Glucocorticoid-Induced Osteoporosis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 2×
“The prolongation of the lifespan of osteoblasts and osteocytes may contribute more than the antiresorptive properties to bone effects of bisphosphonates [14].”
BackgroundUse of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
Self-citationThe epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294 · cited 3×
“A comprehensive review of literature reported a strong inverse relation between cumulative GC dose and BMD [34].”
Self-citationUse of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
A meta-analysis of prior corticosteroid use and fracture risk.
Kanis, J. A., Johansson, H., Oden, A., Johnell, O., de Laet, C., Melton, L. J., Tenenhouse, A., Reeve, J., Silman, A. J., Pols, H. A., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040134 · Cited by 839
Ten Year Probabilities of Osteoporotic Fractures According to BMD and Diagnostic Thresholds
Kanis, J. A., Johnell, O., Oden, A., De Laet, C., Dawson, A., & Jonsson, B. (2001) · Osteoporosis International · doi:10.1007/s001980170006 · Cited by 832
O’Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2004) · Endocrinology · doi:10.1210/en.2003-0990 · Cited by 771
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses
van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Rheumatology · doi:10.1093/rheumatology/39.12.1383 · Cited by 696
Self-citationIntermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis
Adachi, J. D., Bensen, W. G., Brown, J., Hanley, D., Hodsman, A., Josse, R., Kendler, D. L., Lentle, B., Olszynski, W., Ste.-Marie, L.-G., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370603 · Cited by 685
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update
American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1496::aid-art271>3.0.co;2-5 · Cited by 647
Cohen, S., Levy, R. M., Keller, M., Boling, E., Emkey, R. D., Greenwald, M., Zizic, T. M., Wallach, S., Sewell, K. L., Lukert, B. P., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11<2309::aid-anr8>3.0.co;2-k · Cited by 613
Reid, D. M., Hughes, R. A., Laan, R. F. J. M., Sacco-Gibson, N. A., Wenderoth, D. H., Adami, S., Eusebio, R. A., & Devogelaer, J.-P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1006 · Cited by 592
Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., & Cooper, C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11283 · Cited by 559
Lane, N. E., Sanchez, S., Modin, G. W., Genant, H. K., Pierini, E., & Arnaud, C. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3914 · Cited by 529
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Canalis, E. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3441 · Cited by 463
Laan, R. F. J. M., van Riel, P. L. C. M., van de Putte, L. B. A., van Erning, L. J. T. O., van't Hof, M. A., & Lemmens, J. A. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00001 · Cited by 411
van Rossum, E. F. C. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.333 · Cited by 381
Apoptosis of Osteocytes in Glucocorticoid-Induced Osteonecrosis of the Hip1
Weinstein, R. S., Nicholas, R. W., & Manolagas, S. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6714 · Cited by 378
Intestinal Calcium Absorption in Exogenous Hypercortisonism
Klein, R. G., Arnaud, S. B., Gallagher, J. C., Deluca, H. F., & Riggs, B. L. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108762 · Cited by 362
INTERMITTENT ETIDRONATE THERAPY TO PREVENT CORTICOSTEROID- INDUCED OSTEOPOROSIS
Dachi, J. O. D. A., Ensen, W. I. G. B., Acques, J., Rown, B., Anley, D. A. H., Osse, R. O. J., Endler, D. A. L. K., Entle, B. R. L., Lszynski, W. O. O., Ouis, L., et al. (1997) · Cited by 360
The role of the immune system in the pathophysiology of osteoporosis
Clowes, J. A., Riggs, B. L., & Khosla, S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00334.x · Cited by 359
Rheumatoid arthritis, corticosteroid therapy and hip fracture.
Cooper, C., Coupland, C., & Mitchell, M. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.1.49 · Cited by 352
Weinstein, R. S., Chen, J.-R., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214538 · Cited by 313
Carbonare, L. D., Arlot, M. E., Chavassieux, P. M., Roux, J. P., Portero, N. R., & Meunier, P. J. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.1.97 · Cited by 309
Effects of inhaled glucocorticoids on bone density in premenopausal women.
Israel, E., Banerjee, T. R., Fitzmaurice, G. M., Kotlov, T. V., LaHive, K., & LeBoff, M. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002304 · Cited by 303
Oral glucocorticoid use is associated with an increased risk of fracture
Steinbuch, M., Youket, T. E., & Cohen, S. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1548-3 · Cited by 277
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease
Walsh, L. J. (2001) · Thorax · doi:10.1136/thorax.56.4.279 · Cited by 253
Inflammatory bowel disease and the risk of fracture
Van staa, T.-P., Cooper, C., Samuels Brusse, L., Leufkens, H., Javaid, M. K., & Arden, N. K. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.027 · Cited by 245
Self-citationVertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.
Luengo, M., Picado, C., Del Rio, L., Guanabens, N., Montserrat, J. M., & Setoain, J. (1991) · Thorax · doi:10.1136/thx.46.11.803 · Cited by 241
Watts, N. B., Cooper, C., Lindsay, R., Eastell, R., Manhart, M. D., Barton, I. P., van Staa, T.-P., & Adachi, J. D. (2004) · Journal of Clinical Densitometry · doi:10.1385/jcd:7:3:255 · Cited by 229
Self-citationThe Risk of Osteoporosis in Caucasian Men and Women with Obstructive Airways Disease
Sin, D. D., Man, J. P., & Man, S. F. P. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01297-4 · Cited by 225
Effects of Low-Dose Prednisone on Bone Metabolism
Ton, F. N., Gunawardene, S. C., Lee, H., & Neer, R. M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041125 · Cited by 223
Calcium and vitamin D for corticosteroid-induced osteoporosis
Homik, J., Suarez-Almazor, M. E., Shea, B., Cranney, A., Wells, G. A., & Tugwell, P. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000952 · Cited by 202
Molecular mechanisms of glucocorticoid-induced osteoporosis.
Patschan, D., Loddenkemper, K., & Buttgereit, F. (2001) · Bone · doi:10.1016/s8756-3282(01)00610-x · Cited by 201 · cited 2×
“Moderate doses of oral GCs inhibit synthesis of bone collagen by pre-existing osteoblasts and conversion of precursor into functioning osteoblasts [5, 6].”
BackgroundInhaled Corticosteroids and Hip Fracture: A Population-based Case–Control Study
Hubbard, R. B., Smith, C. J. P., Smeeth, L., Harrison, T. W., & Tattersfield, A. E. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-606oc · Cited by 193
Roux, C., Oriente, P., Laan, R., Hughes, R. A., Ittner, J., Goemaere, S., Di Munno, O., Pouillès, J. M., Horlait, S., & Cortet for the ciblos study group, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4742 · Cited by 167
A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids
van Staa, T.-P., Geusens, P., Pols, H. A. P., de Laet, C., Leufkens, H. G. M., & Cooper, C. (2005) · QJM · doi:10.1093/qjmed/hci029 · Cited by 161
Self-citationCorticosteroids and Fractures: A Close Encounter of the Third Cell Kind
Manolagas, S. C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1001 · Cited by 151
Fluoride for the Treatment of Postmenopausal Osteoporotic Fractures: A Meta-Analysis
Haguenauer, D., Welch, V. A., Shea, B., Tugwell, P., Adachi, J. D., & Wells, G. (2000) · Osteoporosis International · doi:10.1007/s001980070051 · Cited by 142
Normal bone mineral density following cure of Cushing's syndrome
Manning, P. J., Evans, M. C., & Reid, I. R. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01437.x · Cited by 140
Sambrook, P. N., Kotowicz, M. A., Nash, P. T., Styles, C. B., Naganathan, V., Briffa, K., Eisman, J. A., & Nicholson, G. C. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.919 · Cited by 138
Severity of obstructive airway disease and risk of osteoporotic fracture
de Vries, F., van Staa, T. P., Bracke, M., Cooper, C. C., Leufkens, H. G. M., & Lammers, J. J. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00058204 · Cited by 137
Richy, F. F., Bousquet, J. J., Ehrlich, G. E., Meunier, P. J., Israel, E., Morii, H., Devogelaer, J., Peel, N. F. A., Haim, M., Bruyère, O., et al. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1398-z · Cited by 134
Influence of Glucocorticoids on Human Osteoclast Generation and Activity
Sivagurunathan, S., Muir, M. M., Brennan‐Speranza, T. C., Seale, J. P., & Mason, R. S. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041233 · Cited by 134
Amin, S., LaValley, M. P., Simms, R. W., & Felson, D. T. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.8.1512 · Cited by 127
Death of osteocytes turns off the inhibition of osteoclasts and triggers local bone resorption
Gu, G., Mulari, M., Peng, Z., Hentunen, T. A., & Väänänen, H. K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.211 · Cited by 123
Jones, A. S., Fay, J. K., Burr, M. L., Stone, M. D., Hood, K., & Roberts, G. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003537 · Cited by 121
Fracture risk associated with systemic and topical corticosteroids
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01467.x · Cited by 120
Contrasting Microanatomy of Idiopathic and Corticosteroid-Induced Osteoporosis
Aaron, J. E., Francis, R. M., Peacock, M., & Makins, N. B. (1989) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198906000-00044 · Cited by 116
Corticosteroids Do Not Alter the Threshold for Vertebral Fracture
Selby, P. L., Halsey, J. P., Adams, K., Klimiuk, P. S., Knight, S. M., Pal, B., Stewart, I. M. G., & Swinson, D. R. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.5.952 · Cited by 92
Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis
Gu, G., Hentunen, T. A., Nars, M., Härkönen, P. L., & Väänänen, H. K. (2005) · APOPTOSIS · doi:10.1007/s10495-005-1893-0 · Cited by 83
Buxton, E. C., Yao, W., & Lane, N. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032066 · Cited by 79
Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects
Paz-Pacheco, E. T., Fuleihan, G. E., & LeBoff, M. S. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101114 · Cited by 79
Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease
Hopkinson, N. S., Man, W. D., Dayer, M., Ross, E. T., Nickol, A. H., Hart, N., Moxham, J., & Polkey, M. I. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00139003 · Cited by 77
Histomorphometric analysis of glucocorticoid-induced osteoporosis
Carbonare, L. D., Bertoldo, F., Valenti, M. T., Zenari, S., Zanatta, M., Sella, S., Giannini, S., & Cascio, V. L. (2005) · Micron · doi:10.1016/j.micron.2005.07.009 · Cited by 76
The Effect of Corticosteroids on Inspiratory Muscle Performance in Humans
WEINER, P., Azgad, Y., & Weiner, M. (1993) · CHEST Journal · doi:10.1378/chest.104.6.1788 · Cited by 59
Lekamwasam, S., Trivedi, D. P., & Khaw, K. (2002) · Osteoporosis International · doi:10.1007/s001980200097 · Cited by 58
Frediani, B., Falsetti, P., Baldi, F., Acciai, C., Filippou, G., & Marcolongo, R. (2003) · Bone · doi:10.1016/s8756-3282(03)00208-4 · Cited by 53
Effects of Inhaled Glucocorticoids on Bone Density in Premenopausal Women
Israel, E., Banerjee, T. R., Fitzmaurice, G. M., Kotlov, T. V., LaHive, K., & LeBoff, M. S. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200202000-00021 · Cited by 49
van Staa, T. P., Geusens, P., Zhang, B., Leufkens, H. G. M., Boonen, A. E. R. C. H., & Cooper, C. C. (2006) · Rheumatology · doi:10.1093/rheumatology/kel249 · Cited by 47
Mayoux-Benhamou, M. A., Roux, C., Perraud, A., Fermanian, J., Rahali-Kachlouf, H., & Revel, M. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1697-z · Cited by 40
Sato, S., Ohosone, Y., Suwa, A., Yasuoka, H., Nojima, T., Fujii, T., Kuwana, M., Nakamura, K., Mimori, T., & Hirakata, M. (2003) · PubMed · Cited by 39
Johannes, C. B., Schneider, G. A., Dube, T. J., Alfredson, T. D., Davis, K. J., & Walker, A. M. (2005) · CHEST Journal · doi:10.1378/chest.127.1.89 · Cited by 33
Determining causation—A case study: Adrenocorticosteroids and osteoporosis
Guyatt, G. H., Webber, C. E., Mewa, A., & Sackett, D. L. (1984) · Journal of Chronic Diseases · doi:10.1016/0021-9681(84)90100-0 · Cited by 31
The population risk of fractures attributable to oral corticosteroids
Donnan, P. T., Libby, G., Boyter, A. C., & Thompson, P. E. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1075 · Cited by 28
Principles of Corticosteroid Therapy
Lin, A. N., & Paget, S. A. (1998) · Cited by 19
Bone Loss and Inhaled Glucocorticoids
van Staa, T. P., Leufkens, B., & Cooper, C. C. (2002) · New England Journal of Medicine · doi:10.1056/nejm200202143460716 · Cited by 17
Cited by
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
Saag, K. G., Shane, E., Boonen, S., Marín, F., Donley, D. W., Taylor, K. A., Dalsky, G. P., & Marcus, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071408 · Cited by 914
Reid, D. M., Devogelaer, J.-P., Saag, K., Roux, C., Lau, C.-S., Reginster, J.-Y., Papanastasiou, P., Ferreira, A., Hartl, F., Fashola, T., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60250-6 · Cited by 527
Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Chotiyarnwong, P., & McCloskey, E. V. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0341-0 · Cited by 489
The epidemiology of glucocorticoid-associated adverse events
McDonough, A. K., Curtis, J. R., & Saag, K. G. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282f51031 · Cited by 405
Metadata
- Authors
- van Staa, T. P.
- Venue
- Calcified Tissue International
- Published
- 2006-09
- Volume
- 79
- Issue
- 3
- Pages
- 129-137
- ISSN
- 0171-967X (ISSN-L)
- 1432-0827
- OpenAlex
- W2140470606
- Cited by
- 260
- References
- 72
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.